Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes. Sections of the manuscript have been updated to be concordant with the most recent update to the guidelines. This manuscript focuses on the available systemic therapy approaches, specifically the treatment options for locally advanced and metastatic disease.

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2021.0017DOI Listing

Publication Analysis

Top Keywords

pancreatic adenocarcinoma
8
pancreatic cancer
8
pancreatic
4
adenocarcinoma version
4
version 22021
4
22021 nccn
4
nccn clinical
4
clinical practice
4
practice guidelines
4
guidelines oncology
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!